UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2001, 1, ISBN 9780520229136, xliv, 375 p. ; 23 cm.
Book
Clinical infectious diseases, ISSN 1058-4838, 9/2015, Volume 61, Issue suppl 2, pp. S69 - S78
telavancin | necrotizing infections | skin infections | cellulitis | soft-tissue infections | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Skin Diseases, Bacterial - microbiology | Humans | Skin Diseases, Bacterial - drug therapy | Oxazolidinones - therapeutic use | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Gram-Positive Bacterial Infections - microbiology | Soft Tissue Infections - drug therapy | Staphylococcal Infections - microbiology | Daptomycin - therapeutic use | Staphylococcal Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Gram-Negative Bacterial Infections - drug therapy | Clinical Trials as Topic | Soft Tissue Infections - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Daptomycin - pharmacology | Soft Tissue Infections - microbiology | Staphylococcal Infections - epidemiology | Oxazolidinones - pharmacology | Gram-Negative Bacterial Infections - epidemiology | Anti-Bacterial Agents - pharmacology | North America - epidemiology | Aminoglycosides - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Aminoglycosides - therapeutic use | Staphylococcus infections | Antimicrobial agents | Mortality | Medical treatment | Morbidity | Streptococcus infections | Index Medicus
Journal Article
The Journal of hospital infection, ISSN 0195-6701, 2008, Volume 70, Issue 2, pp. 3 - 10
Infectious Disease | Sealant | Surgical site infections | Skin asepsis | Epidemiology | Wound contamination | Guidelines | Public, Environmental & Occupational Health | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Human infectious diseases. Experimental studies and models | Biological and medical sciences | General aspects | Infectious diseases | Medical sciences | Guidelines as Topic | Surgical Wound Infection - epidemiology | Gram-Negative Bacteria | Humans | Risk Factors | Antibiotic Prophylaxis | Infection Control - methods | Gram-Positive Bacterial Infections - epidemiology | Incidence | Gram-Negative Bacterial Infections - microbiology | Surgical Wound Infection - prevention & control | Gram-Positive Bacterial Infections - microbiology | Gram-Negative Bacterial Infections - epidemiology | Gram-Negative Bacterial Infections - prevention & control | Surgical Wound Infection - microbiology | Gram-Positive Bacterial Infections - prevention & control | Gram-Positive Cocci | Microbiology | Health aspects | Surgery | Water quality | Index Medicus
Journal Article
Antimicrobial agents and chemotherapy, ISSN 0066-4804, 07/2019, Volume 63, Issue 7
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Microbiology | Science & Technology | Klebsiella pneumoniae - isolation & purification | Pseudomonas aeruginosa - isolation & purification | Enterococcus faecalis - drug effects | Klebsiella pneumoniae - drug effects | Community-Acquired Infections - epidemiology | Humans | Bacteremia - microbiology | Microbial Sensitivity Tests | Klebsiella Infections - epidemiology | Gram-Positive Bacterial Infections - microbiology | Acinetobacter baumannii - isolation & purification | Staphylococcal Infections - microbiology | Drug Resistance, Bacterial - drug effects | Acinetobacter Infections - microbiology | Latin America - epidemiology | Staphylococcus aureus - isolation & purification | Europe - epidemiology | Klebsiella Infections - microbiology | Pseudomonas aeruginosa - drug effects | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Enterococcus faecalis - isolation & purification | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Acinetobacter baumannii - drug effects | Staphylococcus aureus - drug effects | Community-Acquired Infections - microbiology | Index Medicus
Journal Article
Advanced drug delivery reviews, ISSN 0169-409X, 11/2014, Volume 78, pp. 3 - 13
β-Lactamases | Acinetobacter baumannii | Methicillin-resistant Staphylococcus aureus | Antimicrobial resistance | Carbapenem resistance | Vancomycin-resistant enterococci | Enterobacteriaceae | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | beta-Lactam Resistance | Global Health | Gram-Positive Bacteria - drug effects | Humans | Gram-Negative Bacterial Infections - drug therapy | Gram-Negative Bacteria - isolation & purification | Gram-Positive Bacterial Infections - epidemiology | Gram-Negative Bacterial Infections - microbiology | Gram-Negative Bacteria - drug effects | Animals | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - microbiology | Gram-Negative Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Anti-Bacterial Agents - pharmacology | Gram-Positive Bacterial Infections - drug therapy | Index Medicus
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Gastroenterology. Liver. Pancreas. Abdomen | Biological and medical sciences | Medical sciences | Liver. Biliary tract. Portal circulation. Exocrine pancreas | Other diseases. Semiology | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology | Index Medicus
Journal Article
2001, World Bank technical paper, ISBN 0821349643, Volume no. 510, vii, 63
Tuberculosis | AIDS (Disease) | PUBLIC HEALTH CARE | CRIME | PHYSIOTHERAPY | HIV INFECTIONS | VICTIMS | BUDGETARY ALLOCATIONS | CITIZENS | EMIGRATION | WASTE | DRUG USERS | HEALTH SECTOR | ALCOHOL | INCOME DISTRIBUTION | REPUBLICS | REHABILITATION | HOMELESSNESS | FISCAL | PRISONS | BIRTH RATE | PRIMARY SCHOOLS | AIR | RESOURCE DISTRIBUTION | AUTHORITY | DECENTRALIZATION | STATE BUDGETS | FOREIGN EXCHANGE | HEALTH SERVICES | URBAN AREAS | GIRLS | NATIONS | MORTALITY | PUBLIC HEALTH | PATIENTS | TUBERCULOSIS | HOSPITALS | PHC | SOCIAL CAPITAL | INSTITUTIONAL ARRANGEMENTS | INCOME | MIGRANTS | SCREENING | AGED | SOCIAL POLICY | PROSTITUTION | HEALTH INSURANCE | STIS | FINANCIAL CRISIS | HIV | ADOLESCENTS | HEALTH EXPENDITURES | SOCIOECONOMIC CONDITIONS | COMMUNIST | PRIMARY HEALTH CARE | SURGERY | TUBERCULOSIS PREVENTION | DISEASE SURVEILLANCE | IMMUNOLOGIC DISEASES | LIVING STANDARDS | PER CAPITA EXPENDITURES | GONORRHEA | MORTALITY RATES | DISEASE PREVENTION & CONTROL | INSOLVENCY | BUDGETARY RESOURCES | PUPILS | IMMIGRATION | LIFE EXPECTANCY | VENEREAL DISEASES | INFECTIOUS DISEASES | DECREE | LABOR MARKET | DRUG RESISTANT DISEASES | RISK GROUPS | PRIME MINISTERS | DISEASE TRANSMISSION | FISCAL DEFICIT | HEALTH STATUS | SEXUALLY TRANSMITTED INFECTIONS | ACQUIRED IMMUNE DEFICIENCY SYNDROME | SYPHILIS | SMOKING | HEALTH FACILITIES | UNEMPLOYMENT | INSOLVENCY SYSTEMS | PHARMACEUTICAL INDUSTRY | DEPRESSION | WORLD HEALTH ORGANIZATION | YOUNG ADULTS AUTOIMMUNE DISEASES | FOREIGN DIRECT INVESTMENT | HIV INFECTION | DISEASE VECTORS | FOREIGN TRADE | PUBLIC EXPENDITURES | HEALTH CARE | ECONOMICS | EPIDEMICS | ALCOHOLISM | EPIDEMIOLOGY
Book
Clinical infectious diseases, ISSN 1058-4838, 8/2004, Volume 39, Issue 3, pp. 309 - 317
Intensive care units | Pathogens | Surveillance | Major Articles | Antimicrobials | Mortality | Antibiotic resistance | Infections | Blood | Staphylococcus | Neutropenia | General aspects | Infectious diseases | Bacterial diseases | Human bacterial diseases | Staphylococcal infections, streptococcal infections, pneumococcal infections | Biological and medical sciences | Medical sciences | Bacterial sepsis | United States - epidemiology | Prospective Studies | Humans | Middle Aged | Candidiasis - epidemiology | Child, Preschool | Infant | Male | Incidence | Aged, 80 and over | Adult | Female | Child | Cross Infection - epidemiology | Sepsis - epidemiology | Gram-Positive Bacterial Infections - epidemiology | Drug Resistance, Microbial | Staphylococcal Infections - epidemiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | Aged | Fungemia - epidemiology | Causality | Population Surveillance | United States | Causes of | Cross infection | Research | Nosocomial infections | Risk factors | Morbidity | Index Medicus
Journal Article
Comparative immunology, microbiology and infectious diseases, ISSN 0147-9571, 2014, Volume 37, Issue 2, pp. 97 - 108
Infectious Disease | Allergy and Immunology | Cats | Survey | Dermatological infection | Urinary | Marbofloxacin | Dogs | Otitis | Antimicrobial susceptibility | Fluoroquinolone | Respiratory | Veterinary Sciences | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Dog Diseases - epidemiology | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Otitis - microbiology | Dog Diseases - microbiology | Cat Diseases - drug therapy | Skin Diseases, Bacterial - drug therapy | Otitis - drug therapy | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Respiratory Tract Infections - microbiology | Dog Diseases - drug therapy | Urinary Tract Infections - veterinary | Skin Diseases, Bacterial - epidemiology | Otitis - veterinary | Drug Resistance, Multiple, Bacterial | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Cat Diseases - epidemiology | Gram-Negative Bacterial Infections - veterinary | Gram-Positive Bacteria - growth & development | Respiratory Tract Infections - veterinary | Gram-Positive Bacterial Infections - veterinary | Europe - epidemiology | Epidemiological Monitoring - veterinary | Gram-Negative Bacterial Infections - drug therapy | Respiratory Tract Infections - drug therapy | Treatment Outcome | Urinary Tract Infections - drug therapy | Gram-Positive Bacterial Infections - epidemiology | Cat Diseases - microbiology | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Animals | Fluoroquinolones - pharmacology |